Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients

Overview of attention for article published in BMC Cancer, September 2010

Altmetric Badge

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 1 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

Summary Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)

Article in Diagnostics (March 2024)

3-D Structure of Novel Liver Cancer Biomarker LC-SPIK and Its Performance in Clinical Diagnosis of HCC

Preprint in Preprints.org (February 2024)

Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status

Article in Cancers (June 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.